Annexon, Inc. - COMMON STOCK (ANNX)

CUSIP: 03589W102

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+35,062,963
Put/Call ratio
62%
SEC-reported price per share
$5.02
Number of holders
169
Value change
+$183,807,666
Number of buys
111
Open additional details 1 more signal available
Number of sells
45
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
163,738,683

Security key

03589W102

Report period

Q4 2025

Institutions

169

Top holders

10

Ownership snapshot

Top reported holders of ANNX - Annexon, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Satter Muneer A.
Disclosed value leader
Satter Muneer A.
Comparable rows
3/15
Latest evidence
19 Nov 2025
13D/G 13F 3/4/5 Lead comparable stake: 7.2% 12 rows are not safely comparable across share classes. 13D/G row: Satter Muneer A. Showing 1-6 of 15 holder rows.

Quick read

Satter Muneer A. leads the comparable SEC ownership view at 7.2%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Satter Muneer A.'s linked filing trail.
Comparable ownership Top 3
Satter Muneer A. 7.2%
Bain Capital Life Sciences Fund, ... 4.9%
Point72 Asset Management, L.P. 0.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Satter Muneer A.
13D/G
7.2%
Reported 13D/G · 19 Nov 2025
$36,032,262
10,444,134 shares
$0 19 Nov 2025
Bain Capital Life Sciences Fund, L.P.
13D/G
BCLS I Investco, LP
4.9%
Reported 13D/G · 31 Dec 2024
$9,973,231
5,249,069 shares
$0 31 Dec 2024
Point72 Asset Management, L.P.
13F 13D/G
Company
0.1%
Reported 13D/G · 31 Mar 2025
$274,650
90,049 shares
— 30 Sep 2025
Bain Capital Life Sciences Investors, LLC
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$24,428,590
5,401,926 shares
— 25 May 2023
FMR LLC
13F
Company
13F
—
denominator unverified
$33,797,548
11,081,163 shares
— 30 Sep 2025
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$24,091,974
7,899,008 shares
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
169
Shares
136,923,781
Rows available
169
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
143
Q4 2025 holders
169
Holder diff
26
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .